Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension

NCT07356375 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Sao Paulo General Hospital